PYR Test in Microbiology: Principle and Protocol
The PYR test is a rapid biochemical assay used in diagnostic microbiology to detect the enzyme L-pyrrolidonyl arylamidase, which hydrolyzes the substrate L-pyrrolidonyl-beta-naphthylamide to produce a colored end product. This test is primarily used for the presumptive identification of group A streptococci (Streptococcus pyogenes) and enterococci, providing results within minutes instead of days. Laboratory students, technicians, researchers, and diagnostic professionals use this test to differentiate these clinically significant organisms from other catalase-negative, gram-positive cocci that may appear similar on culture media. This article explains the principle behind the PYR test, provides a step-by-step protocol for performing it, and discusses interpretation, quality control, limitations, and documentation requirements.
Clinical Significance of PYR-Positive Organisms
Group A streptococci and enterococci are clinically important pathogens that require accurate and timely identification. Streptococcus pyogenes causes pharyngitis, impetigo, scarlet fever, and invasive infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. Enterococci, particularly Enterococcus faecalis and Enterococcus faecium, are leading causes of hospital-acquired infections including urinary tract infections, bacteremia, and endocarditis. These organisms also demonstrate increasing antimicrobial resistance, making accurate identification essential for appropriate patient management.
The PYR test offers a practical advantage over traditional identification methods. Group A streptococci can be differentiated from other beta-hemolytic streptococci using bacitracin susceptibility testing, but this method requires 18 to 24 hours of additional incubation. The PYR test provides results in under 5 minutes, allowing laboratories to report presumptive identification on the same day that growth is observed. Similarly, enterococci can be differentiated from group D streptococci using the PYR test combined with bile esculin testing, since both organism groups hydrolyze esculin but only enterococci are PYR positive.
Principle of the PYR Test
The PYR test detects the presence of the enzyme L-pyrrolidonyl arylamidase, also known as pyrrolidonyl peptidase. This enzyme is produced by group A streptococci, enterococci, and a limited number of other organisms including some coagulase-negative staphylococci and Aerococcus species. The test substrate is L-pyrrolidonyl-beta-naphthylamide, which the enzyme cleaves to release beta-naphthylamide.
After enzymatic cleavage, a color developer reagent is added. The developer, typically containing p-dimethylaminocinnamaldehyde, reacts with the liberated beta-naphthylamide to produce a red or pink color. The intensity of the color reaction correlates with the amount of enzyme present and the duration of incubation. A positive reaction produces a distinct red color within 1 to 2 minutes after adding the developer reagent. A negative reaction produces no color change or a faint yellow color that matches the reagent itself.
The test can be performed using either a disk format or a broth format. The disk method involves inoculating a filter paper disk impregnated with the substrate and then adding the developer reagent. The broth method uses a tube containing the substrate solution, which is inoculated with a heavy suspension of the test organism. Both formats rely on the same enzymatic reaction and produce comparable results when performed correctly.
At a Glance: PYR Test Summary
| Test Component | Description | Interpretation |
|---|---|---|
| Substrate | L-pyrrolidonyl-beta-naphthylamide on disk or in broth | Cleaved by L-pyrrolidonyl arylamidase enzyme |
| Developer reagent | p-dimethylaminocinnamaldehyde solution | Reacts with free beta-naphthylamide to produce red color |
| Positive control | Streptococcus pyogenes ATCC 19615 | Red color develops within 1 to 2 minutes |
| Negative control | Streptococcus agalactiae ATCC 13813 | No color change after adding developer |
| Test organism | Heavy suspension of pure culture | Must be fresh growth, 18 to 24 hours old |
| Reading time | 1 to 2 minutes after adding developer | Do not read after 5 minutes due to fading |
| Result | Red color equals positive, no color equals negative | Presumptive identification requires correlation with other tests |
Required Materials and Reagents
The PYR test requires minimal materials that are readily available in most clinical microbiology laboratories. Commercial PYR disks or broth tubes are available from multiple manufacturers and include the substrate impregnated on the disk or dissolved in the broth. The developer reagent is supplied separately and must be stored according to manufacturer instructions, typically refrigerated and protected from light.
Additional materials include sterile inoculating loops or swabs, a pure culture of the test organism grown on sheep blood agar, and control organisms for quality testing. A timer or clock is needed to ensure accurate reading times. No specialized equipment such as incubators or centrifuges is required for the disk method, making this test suitable for laboratories with limited resources.
The World Health Organization Laboratory Quality Management System Handbook emphasizes that all reagents must be labeled with preparation and expiration dates and that quality control testing must be performed before new lots are placed into service. Laboratories should document the lot numbers of PYR disks and developer reagent in their quality records.
Step-by-Step PYR Test Protocol
Specimen and Culture Requirements
The PYR test requires a pure culture of the test organism grown on sheep blood agar for 18 to 24 hours. Fresh growth is essential because older cultures may lose enzymatic activity, producing false-negative results. The organism must be isolated in pure culture before testing, since mixed cultures can produce ambiguous results.
For suspected group A streptococci, the test is typically performed on colonies showing beta-hemolysis on sheep blood agar. For suspected enterococci, the test is performed on colonies that are catalase negative, gram-positive cocci in pairs or short chains, and capable of growth in 6.5% sodium chloride broth. The PYR test should not be performed on colonies from selective media such as colistin-nalidixic acid agar because the medium components may interfere with the enzymatic reaction.
Disk Method Procedure
Using a sterile inoculating loop or swab, pick 2 to 3 isolated colonies of the test organism and apply them directly to the PYR disk. The inoculum should be heavy enough to produce a visible smear on the disk surface. Rub the colonies onto the disk to ensure adequate organism contact with the substrate.
Add 1 drop of the developer reagent to the inoculated disk. Observe the disk for color development over 1 to 2 minutes. A positive reaction produces a red or pink color on the disk within this time frame. A negative reaction produces no color change, and the disk remains yellow or colorless.
Broth Method Procedure
For the broth method, use a sterile loop to transfer 2 to 3 colonies into a tube containing the PYR substrate solution. Emulsify the colonies thoroughly to create a heavy suspension. Incubate the tube at 35 to 37 degrees Celsius for 4 hours, although some manufacturers recommend shorter incubation periods.
After incubation, add 2 to 3 drops of the developer reagent to the broth. A red color indicates a positive reaction. The broth method is more sensitive than the disk method but requires longer turnaround time, making it less practical for same-day identification.
Reading and Recording Results
Read the test result within 1 to 2 minutes after adding the developer reagent. Delayed reading can produce false-negative results because the color may fade. Record the result as positive, negative, or invalid in the laboratory information system or worksheet.
A positive PYR test provides presumptive identification of group A streptococci or enterococci, depending on the other phenotypic characteristics of the organism. For beta-hemolytic, catalase-negative, gram-positive cocci, a positive PYR test is presumptive for Streptococcus pyogenes. For non-hemolytic or gamma-hemolytic, catalase-negative, gram-positive cocci that are bile esculin positive, a positive PYR test is presumptive for enterococci.
Quality Control Procedures
Quality control testing is essential to ensure that PYR disks and developer reagent are functioning correctly. The World Health Organization Laboratory Quality Management System Handbook states that quality control testing must be performed with each new lot of reagents and at regular intervals thereafter, typically weekly or monthly depending on laboratory policy and test volume.
Positive Control Organism
Streptococcus pyogenes ATCC 19615 is the recommended positive control for the PYR test. This organism produces the enzyme L-pyrrolidonyl arylamidase and should yield a positive reaction within 1 to 2 minutes. The positive control verifies that the substrate is present on the disk and that the developer reagent is capable of producing a color change.
Negative Control Organism
Streptococcus agalactiae ATCC 13813 is the recommended negative control for the PYR test. This organism does not produce the enzyme and should yield a negative reaction. The negative control verifies that the developer reagent does not produce a false-positive color change in the absence of enzymatic activity.
Frequency of Quality Control Testing
Quality control testing should be performed under the following conditions: when a new lot of PYR disks or developer reagent is received, when the test is first implemented in the laboratory, and at regular intervals as defined by the laboratory quality assurance plan. Many laboratories perform quality control testing weekly or with each new shipment of reagents. Results of quality control testing must be documented and reviewed by the laboratory supervisor.
The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance emphasizes that validation of analytical methods requires demonstration of accuracy, precision, and reliability. While this guidance is directed at pharmaceutical analysis, the principle of verifying method performance through systematic testing applies equally to diagnostic microbiology tests such as the PYR test.
Interpretation of Results
Positive PYR Test
A positive PYR test produces a red or pink color within 1 to 2 minutes after adding the developer reagent. The color intensity may vary from light pink to deep red depending on the amount of enzyme produced by the organism and the density of the inoculum. Any visible red or pink color is considered a positive reaction.
For beta-hemolytic, catalase-negative, gram-positive cocci, a positive PYR test is presumptive for Streptococcus pyogenes. This identification should be confirmed by additional tests such as serological grouping or nucleic acid amplification testing if required by laboratory policy or clinical need.
For non-hemolytic, catalase-negative, gram-positive cocci that are bile esculin positive and grow in 6.5% sodium chloride, a positive PYR test is presumptive for enterococci. Species-level identification may be performed using additional biochemical tests or automated identification systems.
Negative PYR Test
A negative PYR test produces no color change after adding the developer reagent. The disk or broth remains yellow or colorless. A negative PYR test indicates that the organism does not produce L-pyrrolidonyl arylamidase.
For beta-hemolytic, catalase-negative, gram-positive cocci, a negative PYR test suggests that the organism is not Streptococcus pyogenes. Other beta-hemolytic streptococci such as Streptococcus agalactiae, Streptococcus dysgalactiae subspecies equisimilis, and groups C and G streptococci are PYR negative. These organisms require additional testing for definitive identification.
For non-hemolytic, catalase-negative, gram-positive cocci, a negative PYR test suggests that the organism is not an enterococcus. Group D streptococci such as Streptococcus bovis and Streptococcus equinus are PYR negative but bile esculin positive. These organisms can be differentiated from enterococci by the PYR test and by their failure to grow in 6.5% sodium chloride.
Invalid Results
An invalid PYR test result occurs when the test cannot be interpreted due to technical problems. Causes of invalid results include inadequate inoculum, expired reagents, failure to add the developer reagent, or reading the test after the recommended time. If an invalid result is obtained, the test should be repeated using fresh reagents and a fresh culture of the organism.
Common Failure Patterns and Troubleshooting
False-Positive Results
False-positive PYR results occur when the test produces a red color in the absence of the target enzyme. This can happen when the inoculum is too heavy, causing the developer reagent to react with cellular components other than beta-naphthylamide. Using 2 to 3 isolated colonies instead of a large mass of growth reduces this risk.
Contamination of the test organism with PYR-positive organisms can also produce false-positive results. The test organism must be pure before testing. If mixed cultures are suspected, the organism should be subcultured to obtain isolated colonies before repeating the PYR test.
Some organisms other than group A streptococci and enterococci are PYR positive, including Aerococcus species, some coagulase-negative staphylococci, and some viridans group streptococci. A positive PYR test must be interpreted in the context of the organism's other phenotypic characteristics, including hemolysis pattern, catalase reaction, and gram stain morphology.
False-Negative Results
False-negative PYR results occur when the test produces no color change despite the presence of the target enzyme. This can happen when the culture is too old, since enzymatic activity decreases as cultures age. Testing cultures that are 18 to 24 hours old instead of older cultures reduces this risk.
Inadequate inoculum can also produce false-negative results. The test requires a heavy suspension of organisms to produce detectable enzyme activity. Using only a single small colony may not provide enough enzyme for a visible reaction.
Failure to add the developer reagent or adding an insufficient amount can produce false-negative results. The developer reagent must be added in the volume specified by the manufacturer, typically 1 drop for the disk method and 2 to 3 drops for the broth method.
Expired or improperly stored reagents can lose activity and produce false-negative results. PYR disks and developer reagent must be stored according to manufacturer instructions and used before the expiration date. The National Center for Advancing Translational Sciences Assay Guidance Manual emphasizes that reagent stability and proper storage are critical for assay performance.
Timing Errors
Reading the test too early or too late can produce incorrect results. The color reaction develops within 1 to 2 minutes after adding the developer reagent. Reading before 1 minute may miss a weak positive reaction. Reading after 5 minutes may produce false-negative results because the color fades over time.
The laboratory should establish a standard reading time and ensure that all technologists follow the same procedure. Using a timer instead of estimating the time improves consistency.
Limitations of the PYR Test
The PYR test is a presumptive test that provides rapid but not definitive identification. Positive results must be interpreted in the context of other phenotypic characteristics and confirmed by additional testing when clinically indicated.
The test does not differentiate between group A streptococci and other PYR-positive organisms. Aerococcus species and some staphylococci produce positive PYR reactions but are morphologically and biochemically distinct from group A streptococci and enterococci. Gram stain morphology, catalase testing, and hemolysis pattern help differentiate these organisms.
The PYR test does not provide species-level identification of enterococci. Enterococcus faecalis, Enterococcus faecium, and other enterococcal species are all PYR positive. Species-level identification requires additional biochemical testing or molecular methods, particularly for antimicrobial susceptibility interpretation.
The test has limited utility for organisms grown on selective or differential media. Components of some media may inhibit the enzymatic reaction or interfere with color development. The PYR test should be performed on organisms grown on sheep blood agar or another nonselective medium.
The National Center for Biotechnology Information provides access to extensive literature on biochemical tests and microbial identification methods. Laboratories should consult current literature and manufacturer instructions for the most up-to-date information on PYR test performance and interpretation.
Records and Documentation
Accurate documentation of PYR test results is essential for patient care and laboratory quality assurance. The laboratory should maintain records that include the patient identifier, specimen type, date and time of testing, test result, and the identity of the technologist performing the test.
Quality control records should document the date of testing, the lot numbers of PYR disks and developer reagent, the results obtained with positive and negative control organisms, and the identity of the technologist. These records must be reviewed by the laboratory supervisor and retained according to laboratory policy and regulatory requirements.
The World Health Organization Laboratory Quality Management System Handbook emphasizes that laboratory records must be complete, accurate, and legible. Records should be written in permanent ink or entered into an electronic laboratory information system. Corrections to records must be made without obscuring the original entry and must include the date and identity of the person making the correction.
Proficiency testing is an important component of quality assurance for the PYR test. Laboratories should participate in external proficiency testing programs that include PYR testing as part of the challenge panel. Unsatisfactory proficiency testing results should trigger investigation and corrective action.
Biosafety Considerations
The PYR test is performed on cultures of potentially pathogenic organisms, including group A streptococci and enterococci. Standard microbiological practices should be followed when handling these organisms, including the use of gloves and laboratory coats, hand washing after handling cultures, and decontamination of work surfaces.
The World Health Organization Laboratory Biosafety Manual provides guidance on the safe handling of microorganisms in the laboratory. Group A streptococci and enterococci are Risk Group 2 organisms that require Biosafety Level 2 practices and facilities. Work with these organisms should be performed in a biological safety cabinet if aerosol-generating procedures are anticipated.
The PYR test itself does not generate significant aerosols when performed using the disk method. However, opening culture plates and preparing inocula can generate aerosols. These procedures should be performed carefully to minimize aerosol production.
Spills of cultures or reagents should be cleaned immediately using an appropriate disinfectant. The laboratory should have a written spill response procedure and the necessary supplies available. Contaminated materials, including used PYR disks and inoculating loops, should be disposed of according to laboratory policy for biohazardous waste.
Professional Escalation Criteria
Laboratory professionals should escalate PYR test results to the clinical team when the result has implications for patient management. A positive PYR test on a beta-hemolytic, catalase-negative, gram-positive coccus should be communicated promptly because Streptococcus pyogenes infections require specific antimicrobial therapy and infection control measures.
A positive PYR test on a non-hemolytic, catalase-negative, gram-positive coccus that is bile esculin positive should be communicated because enterococci may require antimicrobial susceptibility testing and may be resistant to multiple antibiotics. The laboratory should perform susceptibility testing according to established protocols and report results with appropriate interpretive comments.
Discrepant results between the PYR test and other identification methods should be investigated before reporting. If the PYR test is positive but other characteristics suggest a different organism, the test should be repeated and the organism should be identified using additional methods.
The laboratory director or supervisor should be notified when quality control failures occur, when proficiency testing results are unsatisfactory, or when there is evidence of systematic problems with PYR testing. These situations require investigation and corrective action to ensure the reliability of test results.
Comparison with Alternative Identification Methods
The PYR test is one of several methods available for identifying group A streptococci and enterococci. Bacitracin susceptibility testing has traditionally been used to presumptively identify group A streptococci, but this method requires 18 to 24 hours of incubation and may produce equivocal results. The PYR test provides results in minutes and is more specific than bacitracin susceptibility testing.
Serological grouping using latex agglutination or enzyme immunoassay can definitively identify group A streptococci by detecting the Lancefield group A carbohydrate antigen. These methods require additional reagents and are more expensive than the PYR test. Serological grouping is typically reserved for confirmation of PYR-positive results or for identification of PYR-negative beta-hemolytic streptococci.
Automated identification systems such as Vitek 2, MicroScan, and MALDI-TOF mass spectrometry can identify group A streptococci and enterococci with high accuracy. These systems require specialized equipment and are not available in all laboratories. The PYR test provides a rapid, inexpensive alternative for laboratories without access to automated systems.
Nucleic acid amplification tests can detect group A streptococci directly from clinical specimens, providing results within hours. These tests are more sensitive than culture and can detect organisms in specimens with low bacterial loads. However, nucleic acid amplification tests do not provide isolates for antimicrobial susceptibility testing and are more expensive than culture-based methods.
Practical Implementation in the Laboratory
Workflow Integration
The PYR test should be integrated into the laboratory workflow at the point where gram-positive cocci are being characterized. When a catalase-negative, gram-positive coccus is observed on sheep blood agar, the technologist should perform the PYR test in parallel with other rapid tests such as catalase and bile esculin testing.
For beta-hemolytic colonies, the PYR test can be performed immediately upon recognition of the hemolysis pattern. A positive PYR test allows the laboratory to report presumptive identification of Streptococcus pyogenes on the same day that growth is observed, instead of waiting for additional testing.
For non-hemolytic colonies, the PYR test should be performed in conjunction with bile esculin testing and growth in 6.5% sodium chloride. Enterococci are PYR positive, bile esculin positive, and grow in 6.5% sodium chloride. Group D streptococci are PYR negative, bile esculin positive, and do not grow in 6.5% sodium chloride.
Training Requirements
All laboratory personnel who perform the PYR test must receive training on the procedure, interpretation, and quality control requirements. Training should include hands-on practice with known positive and negative control organisms. Competency should be assessed through direct observation and written examination.
The World Health Organization Laboratory Quality Management System Handbook emphasizes that personnel must be qualified for the tasks they perform and that training records must be maintained. The laboratory should document the initial training and ongoing competency assessment for each technologist performing the PYR test.
Cost Considerations
The PYR test is inexpensive compared to other identification methods. The cost of PYR disks and developer reagent is minimal, and the test requires no specialized equipment. The rapid turnaround time reduces labor costs by eliminating the need for additional incubation and testing.
Laboratories should consider the cost of quality control testing when calculating the total cost of PYR testing. Quality control organisms must be maintained and tested regularly, which requires media, reagents, and technologist time. These costs are offset by the rapid turnaround time and the reduced need for additional identification tests.
Common Errors in PYR Testing
Inoculum Errors
Using too little inoculum is a common cause of false-negative PYR results. The test requires a heavy suspension of organisms to produce detectable enzyme activity. Technologists should be trained to apply 2 to 3 isolated colonies to the disk and to rub the colonies onto the disk surface to ensure adequate contact.
Using too much inoculum can cause false-positive results by producing a color reaction that is not specific for the target enzyme. The inoculum should be limited to 2 to 3 colonies, and the test should be read at the recommended time to avoid overinterpretation of weak color changes.
Reagent Errors
Using expired or improperly stored reagents is a common cause of test failure. PYR disks and developer reagent must be stored according to manufacturer instructions, typically refrigerated and protected from light. The expiration date should be checked before each use, and expired reagents should be discarded.
Adding the developer reagent in the wrong volume or at the wrong time can produce incorrect results. The developer reagent should be added immediately after inoculating the disk, and the test should be read at the recommended time. Adding too much developer reagent can dilute the color reaction, while adding too little can prevent color development.
Interpretation Errors
Misinterpreting weak color reactions is a common error in PYR testing. Any visible red or pink color is considered a positive reaction, regardless of intensity. Technologists should be trained to recognize weak positive reactions and to confirm them with repeat testing if necessary.
Reading the test after the recommended time can produce false-negative results because the color fades over time. The test should be read within 1 to 2 minutes after adding the developer reagent, and the reading time should be standardized across all technologists.
Frequently Asked Questions
What organisms are PYR positive?
Group A streptococci (Streptococcus pyogenes) and enterococci are the most clinically significant PYR-positive organisms. Other PYR-positive organisms include Aerococcus species, some coagulase-negative staphylococci, and some viridans group streptococci. The PYR test is used to presumptively identify group A streptococci and enterococci when other phenotypic characteristics support these identifications.
How is the PYR test different from the bacitracin test?
The PYR test detects the enzyme L-pyrrolidonyl arylamidase and provides results within 1 to 2 minutes. The bacitracin test detects susceptibility to bacitracin and requires 18 to 24 hours of incubation. The PYR test is more specific for group A streptococci than the bacitracin test, which can produce false-positive results with some other beta-hemolytic streptococci.
Can the PYR test be used on organisms from selective media?
The PYR test should be performed on organisms grown on sheep blood agar or another nonselective medium. Components of selective media may inhibit the enzymatic reaction or interfere with color development. If the organism is only available on selective media, it should be subcultured to sheep blood agar before PYR testing.
Why is fresh culture important for the PYR test?
Fresh cultures, typically 18 to 24 hours old, have optimal enzymatic activity. Older cultures may lose enzymatic activity, producing false-negative results. Using fresh cultures ensures that the test reflects the organism's true enzymatic capabilities.
What does a positive PYR test mean for a beta-hemolytic streptococcus?
A positive PYR test on a beta-hemolytic, catalase-negative, gram-positive coccus is presumptive for Streptococcus pyogenes. This identification should be confirmed by additional testing such as serological grouping or nucleic acid amplification testing if required by laboratory policy or clinical need.
What does a positive PYR test mean for a non-hemolytic gram-positive coccus?
A positive PYR test on a non-hemolytic, catalase-negative, gram-positive coccus that is bile esculin positive and grows in 6.5% sodium chloride is presumptive for enterococci. Species-level identification may be performed using additional biochemical tests or automated identification systems.
How should quality control be performed for the PYR test?
Quality control should be performed with each new lot of reagents and at regular intervals thereafter. Streptococcus pyogenes ATCC 19615 should be used as the positive control, and Streptococcus agalactiae ATCC 13813 should be used as the negative control. Quality control results must be documented and reviewed by the laboratory supervisor.
What should be done if the PYR test result is discrepant with other test results?
Discrepant results should be investigated before reporting. The PYR test should be repeated using fresh reagents and a fresh culture of the organism. If the discrepancy persists, the organism should be identified using additional methods such as serological grouping, automated identification systems, or molecular testing.
Related Diagnostic Guides
- How to Perform a PYR Test: Principle and Protocol
- How to Perform a Catalase Test: Principle, Procedure, and Interpretation
- How to Perform an Indole Test: Principle, Procedure, and Interpretation
- How to Perform an Oxidase Test: Principle, Procedure, and Interpretation
- Understanding Positive and Negative Controls in Microbiology Experiments
References and Further Reading
- Laboratory Quality Management System Handbook. World Health Organization.
- Laboratory Biosafety Manual. World Health Organization.
- Assay Guidance Manual. National Center for Advancing Translational Sciences.
- Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
- NCBI Literature Resources. National Center for Biotechnology Information.
- NOTA and NODAGA [(99m)Tc]Tc- and [(186)Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [(99m)Tc]Tc-NODAGA Somatostatin Receptor-Targeting Bioconjugate.. Bioconjugate chemistry, 2018.
- Molecular Engineering of Interlayer Exciton Delocalization in 2D Perovskites.. Journal of the American Chemical Society, 2025.
- Chiral Micellar Assemblies for Circularly Polarized Luminescence Amplification, Dye Encapsulation, and Multilevel Information Encryption.. Angewandte Chemie (International ed. in English), 2026.
- Evolutionary-based remodeling of ABA receptors reveals the structural basis of hormone perception and regulation.. Proceedings of the National Academy of Sciences of the United States of America, 2026.
- Inverse Design of 2D Altermagnetic Metal-Organic Framework Monolayers from Hückel Theory of Nonbonding Molecular Orbitals.. JACS Au, 2025.
- A new regulatory principle for in vivo biochemistry: pleiotropic low affinity regulation by the adenine nucleotides--illustrated for the glycolytic enzymes of Saccharomyces cerevisiae.. FEBS letters, 2013.
- Disrupted hippocampal theta-gamma coupling and spike-field coherence following experimental traumatic brain injury.. 2026.
- Flexible goal learning involves coordinated population activity in dCA1 and medial orbitofrontal cortex.. 2026.
- Effects of Isopropyl Alcohol, Tetrahydrofuran, Pyridine, and Acetonitrile on Surface Roughness, Surface Morphology, and Shear Bond Strength Between Composite Resin and Different Provisional Restorative Materials.. 2026.
- In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.. Saudi Medical Journal, 2006.
- Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.. Respiratory Medicine, 2023.
- Gastric Alimetry® Test Interpretation in Gastroduodenal Disorders: Review and Recommendations. Journal of Clinical Medicine, 2023.
This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.